Adastria Co., Ltd. (TYO:2685)

Theseus Pharmaceuticals Revenue

Adastria had revenue of 77.46B JPY in the quarter ending May 31, 2025, with 4.68% growth. This brings the company's revenue in the last twelve months to 296.57B, up 5.50% year-over-year. In the fiscal year ending February 28, 2025, Adastria had annual revenue of 293.11B with 6.35% growth.

• Revenue (ttm): 296.57B
• Revenue Growth: +5.50%
• P/S Ratio: 0.48
• Revenue / Employee: 42.71M
• Employees: 6,944
• Market Cap: 142.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	293.11B	17.51B	6.35%
Feb 29, 2024	275.60B	33.04B	13.62%
Feb 28, 2023	242.55B	40.97B	20.32%
Feb 28, 2022	201.58B	17.71B	9.63%
Feb 28, 2021	183.87B	-38.51B	-17.32%